Cognitive function in Down syndrome-associated Alzheimer’s focus of grant

Nearly every person with Down syndrome eventually develops Alzheimer’s disease, yet people with the syndrome routinely are excluded from Alzheimer’s clinical trials, as the cognitive assessment tools designed for the general population often are inappropriate for people with developmental disabilities. Consequently, nobody knows whether the new Alzheimer’s therapeutics hitting the market will work for people […]

Altered gut bacteria may be early sign of Alzheimer’s disease

­People in the earliest stage of Alzheimer’s disease — after brain changes have begun but before cognitive symptoms become apparent — harbor an assortment of bacteria in their intestines that differs from the gut bacteria of healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis. The findings, […]

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers. The treatment uses genetically modified T cells to target and attack certain types of leukemia and lymphoma. While it can eliminate cancer in some patients who would otherwise succumb to the disease, it also comes with the risk of a range of […]

Risk, resiliency in aging brain focus of $33 million grant

A large study that investigates just what keeps our brains sharp as we age and what contributes to cognitive decline has been launched by researchers from Washington University School of Medicine in St. Louis, Harvard University/Massachusetts General Hospital, the University of Minnesota Medical School and the University of California Los Angeles (UCLA). Known as the […]

Hit the sleep ‘sweet spot’ to keep brain sharp

Like so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short and long sleepers experienced greater cognitive decline than people who slept a moderate amount, even when the effects of early Alzheimer’s disease were taken into account. The study was led by researchers […]

Alzheimer’s in adults with Down syndrome focus of multicenter NIH grant

Researchers from Washington University School of Medicine in St. Louis are taking part in a multisite study to investigate the biomarkers of Alzheimer’s disease in people with Down syndrome. By middle age, nearly all people with Down syndrome show signs of Alzheimer’s disease, and doctors have no way to prevent it or to stop the […]

Older people with early, asymptomatic Alzheimer’s at risk of falls

Falls are the leading cause of fatal injuries in older adults, causing more than 800,000 hospitalizations and about 30,000 deaths in the U.S. every year. Some risk factors are well-known — advanced age, problems with vision or balance, muscle weakness — but an under-recognized factor is early Alzheimer’s disease. Older people in the earliest stages […]

Stark, Ances and Brennan receive NIH National Institute on Aging $3.3 million grant

The National Institutes of Health (NIH)‘s National Institute on Aging has awarded a $3.3 million grant to Susan Stark, associate professor of occupational therapy, and Beau Ances, MD, PhD, the Daniel J. Brennan, MD, Professor of Neurology, both at the School of Medicine, to assess whether falls can be used to predict onset of Alzheimer’s […]

Before it begins: Family, researchers team up to cure — or even prevent — Alzheimer’s disease

From the WashU School of Medicine Outlook Magazine… A bequest by the late Daniel J. Brennan, MD, is supporting significant advancements in Alzheimer’s disease research at the School of Medicine. The disease affects 5.5 million Americans — a number expected to climb rapidly as people live longer. Following Brennan’s death in 2010, the estate gift created the […]

Ances installed as inaugural Brennan Professor

Research focuses on Alzheimer’s diagnosis, treatment From the WashU Newsroom… Beau M. Ances, MD, PhD, has been named the inaugural Daniel J. Brennan, MD, Professor of Neurology at Washington University School of Medicine in St. Louis. Using state-of-the-art imaging techniques, he works to develop diagnostic tools and treatments for Alzheimer’s disease. He was installed by […]